science pharmaceutical expo biotech jobs

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffmann, E.
Right arrow Articles by Kracht, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, E.
Right arrow Articles by Kracht, M.
Related Collections
Right arrowRelated Articles
(Journal of Leukocyte Biology. 2002;72:847-855.)
© 2002 by Society for Leukocyte Biology

Multiple control of interleukin-8 gene expression

Elke Hoffmann, Oliver Dittrich-Breiholz, Helmut Holtmann and Michael Kracht

Institute of Pharmacology, Medical School Hannover, Germany

Correspondence: Dr. Michael Kracht, Institute of Pharmacology, Medical School Hannover, Carl-Neuberg Strasse 1, D-30625 Hannover, Germany. E-mail: Kracht.Michael{at}MH-Hannover.de


arrow
ABSTRACT
 
Interleukin (IL)-8, a prototypic human chemokine, was detected more than a decade ago as the founding member of the chemokine superfamily. One of the most remarkable properties of IL-8 is the variation of its expression levels. In healthy tissues, IL-8 is barely detectable, but it is rapidly induced by ten- to 100-fold in response to proinflammatory cytokines such as tumor necrosis factor or IL-1, bacterial or viral products, and cellular stress. Recently, significant advances in the understanding of signaling pathways, which coordinately regulate IL-8 transcription as well as mRNA stabilization in response to external stimuli, have been made. Maximal IL-8 amounts are generated by a combination of three different mechanisms: first, derepression of the gene promoter; second, transcriptional activation of the gene by nuclear factor-{kappa}B and JUN-N-terminal protein kinase pathways; and third, stabilization of the mRNA by the p38 mitogen-activated protein kinase pathway. In that way, cells are able to rapidly increase and at the same time, to fine-tune the amount of IL-8 secreted and thereby control the extent of leukocytes attracted to sites of tissue injury.

Key Words: MAPK • NF-{kappa}B • interleukin-8 • transcription • mRNA stability


arrow
INTRODUCTION
 
Infection or injury of the body results in inflammation. A hallmark of this response is the recruitment of neutrophils from the blood to the injured tissue. This process is directed by chemotactic polypeptides of 8–14 kD so-called chemokines. About 40 human chemokines are known today [1 ]. Interleukin (IL)-8 was detected more than a decade ago as the founding member of this superfamily [2 ]. Many of its properties, including its three-dimensional structure, receptors, signaling mechanisms, and additional functions in angiogenesis, tumor progression, mitosis, and tissue remodeling, are well-known [2 ]. One of the most remarkable properties of IL-8 is the variation of its expression levels. Normally, IL-8 protein is barely secreted from noninduced cells, but its production is rapidly induced by a very wide range of stimuli encompassing proinflammatory cytokines such as tumor necrosis factor (TNF) or IL-1 [3 , 4 ], bacterial [5 , 6 ] or viral products [7 , 8 ], and cellular stress [9 10 11 12 ]. Remarkably, some stimuli, such as IL-1 or TNF, up-regulate IL-8 by more than 100-fold [3 , 4 , 8 , 12 ], whereas others, such as certain bacteria or epidermal growth factor (EGF), cause a more moderate five- to tenfold increase in IL-8 secretion [5 , 6 , 13 ]. Furthermore, IL-8 can be synthesized by many different cell types (Table 1 ).


View this table:
[in this window]
[in a new window]
  		Table 1. Evidence by Inhibition or Activation for the Involvement of Signalling Pathways in Regulation of IL-8 Expression

This raises the question of by which intracellular pathways cells regulate the extent as well as the duration of IL-8 gene expression. The aim of this review is to highlight recent advances in understanding of the signaling mechanisms involved in IL-8 expression.


arrow
TRANSCRIPTIONAL REGULATION OF IL-8
 
Stimulus-dependent activation of IL-8 gene transcription has been demonstrated in nuclear run-on experiments [3 , 4 ]. In a number of studies, it was found that a sequence spanning nucleotides -1 to -133 within the 5' flanking region of the IL-8 gene is essential and sufficient for transcriptional regulation of the gene (refs. [55 , 56 ] and reviewed in ref. [57 ]). As demonstrated by mutational and deletional analyses, this promotor element contains a nuclear factor (NF)-{kappa}B element that is required for activation in all cell types studied. NF-{kappa}B is a dimeric transcription factor composed of a family of five subunits, namely NF-{kappa}B1 (p50 and its precursor p105), NF-{kappa}B2 (p52 and its precursor p100), and c-REL, REL A (p65), and REL B [58 ]. NF-{kappa}B is retained in the cytoplasm by its binding to inhibitory (I{kappa}B) proteins. I{kappa}B phosphorylation results in ubiquitination and rapid degradation of I{kappa}Bs by the proteasome, allowing NF-{kappa}B to translocate to the nucleus and bind to DNA. This process is critical for NF-{kappa}B activation, but enhanced NF-{kappa}B-induced transcriptional activity might additionally require phosphorylation of the subunits as well as binding of coactivators [58 , 59 ]. By using chromatin immunoprecipitation, binding of p65 NF-{kappa}B to the endogenous IL-8 promoter and subsequent recruitment of RNA polymerase II are found rapidly, within one-half hour of IL-1 stimulation, underscoring the important role of NF-{kappa}B in IL-8 transcription (Fig. 1 ).



View larger version (20K):
[in this window]
[in a new window]
  		Figure 1. IL-1 rapidly stimulates recruitment of p65 NF-{kappa}B and RNA polymerase II to the endogenous IL-8 promoter. HeLa cells were stimulated for 30 min with 10 ng/ml IL-1{alpha} or left untreated. Protein-DNA complexes were cross-linked in intact cells by formaldehyde treatment. Cells were lysed, and p65 NF-{kappa}B (A) or RNA polymerase II (Pol-II; B) was immunoprecipitated with specific antibodies. IL-8 promoter DNA bound to immune complexes was recovered after reversal of cross-links and was detected by polymerase chain reaction (PCR). Shown are PCR products amplified with specific primers, which cover the IL-8 promoter region containing the NF-{kappa}B-binding site and the tata box (as shown in Fig. 2 ) or as a control, a region more than 800 bp 5' in the IL-8 gene. As additional controls, PCR products were amplified with the same primer pairs from increasing amounts of genomic DNA (Input).

The core IL-8 promoter also contains activating protein (AP)-1- and CAAT/enhancer-binding protein (C/EBP)-binding sites (Fig. 2 ). The latter two sites are dispensable for transcriptional activation in some cells, but contribute to activation in others. Thus, unlike the NF-{kappa}B site, the AP-1 and C/EBP sites are not essential for induction but are required for maximal gene expression [3 4 5 6 7 8 , 10 , 57 , 60 , 65 66 67 ].



View larger version (36K):
[in this window]
[in a new window]
  		Figure 2. Regulation of basal and inducible IL-8 transcription. A part of the IL-8 promoter, proximal, regulatory region is illustrated. Identified binding sites for transcription factors are shaded [45, 57, 60]. In unstimulated cells, the IL-8 promoter is repressed by three mechanisms: first, by binding of the NF-{kappa}B-repressing factor (NRF) to the negative regulatory element (NRE) that overlaps the NF-{kappa}B site (solid line) [45]; second, by binding of octamer-1 (OCT-1) to an octamer-binding site located on the complementary strand in the opposite direction of the C/EBP site (dotted line) [67]; and third, by deacetylation of histone proteins by histone deacetylase 1 (HDAC-1) [61]. Upon induction by IL-1{alpha} or TNF-{alpha}, the p65 subunit of NF-{kappa}B translocates to the nucleus and binds to its site in close proximity to NRF [45, 62, 63]. OCT-1 is replaced by C/EBP ß [63 67 ], whereas NRF switches its function to act as a coactivator [45]. Recruitment of CREB-binding protein (CBP)/p300 results in hyperacetylation of histones and chromatin remodeling [64]. As a result, repression of the promoter is relieved. AP-1 and NF-{kappa}B proteins become phosphorylated in a signal-dependent manner (see Fig. 3 ). Collectively, these events facilitate initiation of transcription.

The transcriptional regulator AP-1 is a homo- or heterodimer composed of c-JUN, JUN D, JUN B, ATF-2, c-FOS, FRA-1, FRA-2, and other family members [68 , 69 ]. In contrast to NF-{kappa}B, AP-1 proteins are usually constitutively bound to their cognate DNA element. Transcriptional activity of AP-1 proteins is regulated by their abundance, phosphorylation of transactivation domains, and by their binding to protein kinases [68 , 69 ].

It is important to note that in contrast to NF-{kappa}B, whose p65 subunit binding to the IL-8 promoter has been analyzed at the atomic level [62 ], the composition of the endogenous AP-1 dimer as a function of time and stimulus that modulates IL-8 transcription has not been determined.

Little is known about signaling pathways regulating C/EBPs, including the family member C/EBP-ß (also called NF-IL-6), which was found to bind to the IL-8 promoter [60 , 65 66 67 ]. Therefore, in this review, we will focus on the role of pathways targeting NF-{kappa}B and AP-1 in IL-8 gene expression.


arrow
THE ROLE OF PROTEIN KINASE PATHWAYS REGULATING NF-{kappa}B AND AP-1 IN IL-8 TRANSCRIPTION
 
Virtually all stressful and proinflammatory stimuli known to induce IL-8 production activate a number of protein kinases, which in principal have the capacity to modulate NF-{kappa}B or AP-1 activity.

The rate-limiting step in NF-{kappa}B activation—I{kappa}B proteolysis—is regulated by recently identified I{kappa}B kinases (IKK{alpha}/ß and IKK{gamma}/Nemo), which specifically phosphorylate two adjacent serines in I{kappa}B proteins [70 ]. In contrast, the pathway(s) regulating NF-{kappa}B transactivation, rather than translocation, are less well-defined [59 ].

AP-1 is activated by mitogen-activated protein kinases (MAPK). Three MAPK pathways contribute to IL-8 gene expression, the extracellular-regulated protein kinase (ERK), JUN-N-terminal protein kinase (JNK), and p38 MAPK cascades. There are two closely related ERK (1 and 2), three JNK whose differential splicing gives rise to 10 isoforms, and four p38 MAPK isoforms [68 , 69 , 71 , 72 ]. All of them are activated by phosphorylation through dual-specificity MAPK kinases (MKK). ERK are activated by MKK1 or 2, and JNK are activated by MKK7, whereas p38 MAPK are activated by MKK3 and 6. Additionally MKK4 activates JNK and p38 MAPK. MKK require phosphorylation in the conserved kinase domain VIII for activation by upstream kinases (see below).

Several laboratories have used inactive kinase mutants, antisense RNA, or specific inhibitors to block these pathways at various levels in intact human cells to study their contribution to IL-8 gene expression (see Table 1 ). No mouse homologue of IL-8 is known today [1 ], preventing the analysis of IL-8 expression in mice deficient for any of these signaling molecules. However, information for regulation of IL-6, a cytokine whose expression in many respects is regulated very similar to IL-8 [44 , 59 , 64 ], is available from mice deficient in individual components of the pathways activating NF-{kappa}B and AP-1.

As expected from the essential requirement of the NF-{kappa}B cis-element for IL-8 transcription, inhibition of NF-{kappa}B by dominant-negative mutants of IKKß [42 ] or I{kappa}B [40 , 41 ] or by antisense to NF-{kappa}B [37 38 39 ] strongly impairs IL-1- and TNF-induced transcriptional expression of IL-8 (see also Table 1 ). In line with the importance of NF-{kappa}B for inflammatory gene expression, inducible IL-6 expression is lost in IKKß- and IKK{gamma}-deficient mice [73 , 74 ].

Compared with NF-{kappa}B, the role of JNK in IL-8 regulation is less widely explored. However, JNK, like NF-{kappa}B, are strongly activated under most conditions that induce IL-8. The observation that JNK are in fact essential for IL-8 (and IL-6) expression was made initially in human epithelial cells by blocking JNK activation by stable expression of antisense RNA or by dominant-negative mutants [44 ]. The JNK inhibition was specific and did not affect NF-{kappa}B or p38 MAPK activation [44 ]. The absolute requirement of JNK for IL-6 expression was later confirmed in JNK2-/- fibroblasts [73 ]. Recently, a reversible ATP-competitive inhibitor, the anthrapyrazolone SP600125, was developed, which preferentially inhibits JNK in vitro (Ki 0.19µM) and at concentrations above 5 µM in vivo. However, at higher concentrations (50 µM), it also inhibited p38 MAPK [75 ]. In contrast to the findings above, the inhibitor had no effect on IL-8 expression in lipopolysaccharide (LPS)-stimulated human monocytes [75 ]. Therefore, it remains to be seen if it affects IL-8 expression in other systems.

JNK are the only c-JUN kinases identified to date. Therefore, they are generally thought to activate inflammatory genes via c-JUN and the AP-1 cis-element [76 , 77 ]. However, adenoviral expression of a dominant-negative mutant of c-JUN, in which the transactivation domain was deleted, failed to inhibit IL-8 induction in one report [40 ], but this mutant did affect IL-8 expression in another study [46 ]. These findings are consistent with the known variable contribution of the AP-1 site to IL-8 transcription and may point to a less significant role for c-JUN in IL-8 regulation in some conditions [57 ].

Taken together, available data suggest that the NF-{kappa}B and JNK pathways are indispensable for inducible IL-8 regulation. Blockade of one pathway in the presence of normal activation of the other drastically reduces IL-8 secretion. To further elucidate the individual contribution of NF-{kappa}B and JNK (and also p38; see below), they were activated in the absence of extracellular stimulation. This was achieved by transient expression of constitutively active protein kinase mutants. Although nonphysiological, this approach allows selective activation of individual pathways alone or in combination. Constitutively active MKK7, a specific activator of the JNK pathway, or NF-{kappa}B-inducing kinase (NIK), a specific upstream activator of NF-{kappa}B, induced low IL-8 synthesis and transcription from a minimal IL-8 promotor [13 ]. However, MKK7 synergized in both effects with NIK. Activation of the IL-8 promotor by either of the kinases required functional NF-{kappa}B and AP-1 sites [13 ].

What might be the significance of this pathway cooperativity? The cis-elements for NF-{kappa}B, AP-1, and other transcription factors are located in close proximity within less than 200 base pairs of the IL-8 promoter (refs. [45 , 57 ] and Fig. 2 ). This suggests the formation of higher-order nucleoprotein complexes. Such a complex, termed transcriptional enhanceosome, has been analyzed in detail for the virus-inducible cytokine interferon (IFN)-ß [78 , 79 ]. The purpose of the enhanceosome is to provide a multiprotein surface that makes optimal contact with the proteins of the basal transcriptional machinery and thus facilitates maximal gene transcription [80 ]. Contacts between the proteins are enabled or improved by post-translational modifications, chromatin-remodeling via histone acetylation or histone phosphorylation [81 ], or large coactivator proteins such as p300/CBP [82 ]. The latter provide multidocking platforms and possess intrinsic acetyltransferase activities [83 ].

Indeed, recent observations indicate that enhanceosome-like structures modulate IL-8 expression. CBP/p300 potentiates p65-mediated IL-8 transcription in an acetylation-dependent manner [64 ], whereas the HDAC-1 negatively affects IL-8 promoter activity [61 ]. Using the chromatin immunoprecipitation technique, binding of p65 NF-{kappa}B and the formation of a TNF-stimulated, preinitiation complex at the IL-8 promoter containing inducibly phosphorylated RNA polymerase II were recently demonstrated [84 ].


arrow
THE NUCLEAR PROTEIN NRF IS REQUIRED FOR BASAL AND INDUCIBLE IL-8 TRANSCRIPTION
 
The conclusion that IL-8 transcription is regulated by a multiprotein complex is also supported by the recent identification of a signal-responsive cis-element that overlaps with the NF-{kappa}B-binding site.

IL-8 expression is low in unstimulated cells. This is partly a result of transcriptional repression of the promoter. By sequence comparison with the IFN-ß promoter, a negative regulatory element (NRE) was found in the IL-8 promoter overlapping partially with the NF-{kappa}B response element [85 ]. NF-{kappa}B repressing factor (NRF) binds to the IL-8-promoter NF-{kappa}B-NRE element [45 , 86 ]. Reduction of cellular NRF by expressing NRF-antisense RNA results in spontaneous IL-8 gene expression. In contrast, IL-1-induced IL-8 secretion is strongly impaired by expressing NRF-antisense RNA. Mutation of the NRE site results in loss of NRF binding and increased basal IL-8 transcription. Conversely, IL-1-induced IL-8 transcription is decreased by mutating the NRE element. These data provide evidence for a dual role of the NRF in IL-8 transcription. Although in the absence of stimulation, it is involved in transcriptional silencing, in IL-1-induced cells, it is required for full induction of the IL-8 promoter [45 ].

The mechanism by which NRF contributes to IL-1-induced IL-8-promoter activation remains elusive. Overexpressed NRF alone did not enhance NF-{kappa}B-mediated IL-8 transcription. However, when p65 NF-{kappa}B was expressed together with active nuclear JNK, cotransfected NRF enhanced IL-8 transcription further. These results suggest that NRF is modified itself by a JNK-dependent mechanism or that it is interacting on the IL-8 promoter with kinase-activated transcription factor(s). NRF coactivation required not only an intact NRE site but also binding of NF-{kappa}B and AP-1 proteins to their cis-elements [45 ]. This suggests that the binding of all three transcription factors to their DNA binding sites and their physical interaction is needed for maximal induction of the IL-8 promoter. The NRE overlaps with the NF-{kappa}B site, and indeed, it was shown previously that NRF is able to interact directly with members of the rel family [86 ]. NF-{kappa}B is modified by protein kinases [87 88 89 ], interacts with various proteins that enhance its transcriptional activity [63 , 90 91 92 ], and contacts through its C-terminus components of the basal transcriptional machinery [93 ]. Thus, it is possible that in IL-1-stimulated cells, NRF enhances NF-{kappa}B activity in concert with AP-1 by acting on one or more of these mechanisms. The combination of NF-{kappa}B and NRE sites is conserved in a variety of genes relevant to inflammation [85 , 86 , 94 ]. The NRE element does not overlap the NF-{kappa}B site in all cases. However, it was shown previously that the inhibitory effect of NRE on various NF-{kappa}B elements is exhibited over distances up to 2.5 kbp [86 ]. Thus, it is tempting to speculate that NRF constitutes a major transcription factor, which prevents uncontrolled expression of proinflammatory proteins and contributes to their effective synthesis during disease.

Another mechanism for repression of the IL-8 gene has been described earlier [67 ]. In this model, transcription of the IL-8 promoter is induced by replacing the repressor OCT-1 with NF-{kappa}B and C/EBP as a consequence of IL-1 stimulation [67 ]. In contrast to this competitive mechanism, NRF represses the IL-8 promoter, most likely by a noncompetitive mechanism, as it is not replaced by NF-{kappa}B after stimulation by IL-1 (Fig. 2) , and as outlined above, it alters its function and is required for maximal promoter activity during stimulation.

As summarized in Figure 2 , these findings are best reconciled with a model, whereby IL-8 transcription is effectively repressed in unstimulated cells by a combination of three mechanisms involving deacetylation of histones [61 , 95 ], OCT-1 binding [67 ], and active repression by NRF [45 ].

Induction of strong IL-8 transcription by the cytokines IL-1 and TNF requires the actively promoted formation of an enhanceosome-like structure at the promoter by at least two signals, one provided by nuclear translocation of NF-{kappa}B and the other by activation of the JNK pathway. Presumably, through these pathways, the enhanceosome integrates various external signals by a combinatorial usage of a limited set of activators and thereby is able to regulate the magnitude of IL-8 gene transcription (see Fig. 4 ). Further insight into this mechanism requires the identification of all proteins involved, including the target(s) of JNK.



View larger version (32K):
[in this window]
[in a new window]
  		Figure 4. Quantitative control of IL-8 synthesis by cooperation of at least three signaling pathways. Virtually no IL-8 synthesis is detectable in most cells or tissues as a result of transcriptional repression and destabilization of its mRNA. Activation of NF-{kappa}B alone is essential for transcription of the IL-8 gene but like activation of JNK, results in only low secretion of IL-8. Activation of NF-{kappa}B and JNK (and ERK or other pathways?) results in moderate IL-8 mRNA synthesis and secretion. When a third signal by the p38 MAPK pathway is provided, the transcribed RNA is rapidly stabilized, and high amounts of the protein are produced [13].


arrow
POST-TRANSCRIPTIONAL REGULATION OF IL-8 BY THE P38 MAPK PATHWAY
 
Inhibition of p38 MAPK by the pyridylimidazole analogues SB203580 or 202190 suppresses induction of IL-8 in some cells (Table 1) but not in others [96 ]. Moreover, inhibition of IL-1- and TNF-induced IL-8 secretion by SB compounds is only partial [27 ]. Care should be taken in interpreting many of the data obtained with the SB inhibitors, as at concentrations above 2 µM, they will also inhibit kinases other than p38 [97 ]. However, available data with low concentrations of the drugs suggest that the p38 pathway significantly contributes to IL-8 expression but unlike NF-{kappa}B, is not essential [27 , 29 ]. This interpretation is supported by observations made in MKK3- or p38{alpha}-deficient mice. In these animals, the expression of IL-6 is still inducible by IL-1 or TNF, although to a much lesser extent than in wild-type mice [98 , 99 ].

These findings may be explained by the observation that the p38 MAPK pathway regulates a specific, post-transcriptional step in IL-8 gene expression. The very low amount of IL-8 found in unstimulated cells is not only a result of repressed transcription but also the result of a very unstable mRNA. The rapid adenine and uracil degradation of the IL-8 mRNA is mediated by absorbance unit (AU)-rich cis-elements (ARE) contained in its 3' untranslated region. It is interesting that this part of the mRNA is also required for signal-mediated stabilization of the IL-8 transcript. By measuring IL-8 mRNA stability with tetracycline-regulatable reporter gene constructs [13 , 31 , 43 ], it was recently shown that activation of the p38 MAPK pathway stabilizes the IL-8 mRNA. Specifically, these data showed that an active form of MKK6, which selectively activates p38 MAPK, induced marked stabilization of the IL-8 transcript. In addition, an active form of the protein kinase MAPK-activated protein kinase-2 (MK2), a downstream substrate of the MKK6-p38 MAPK pathway, also induced mRNA stabilization, whereas kinase-negative mutants of p38 MAPK or of MK2 interfered with MKK6-induced stabilization. Furthermore, a dominant-negative mutant of p38 MAPK interfered with mitogen-activated ERK kinase kinase 1 (MEKK1) as well as with IL-1-induced stabilization [13 , 31 , 43 ]. NIK and MKK7, which as outlined above, cooperatively induce IL-8 transcription, did not affect degradation of IL-8 mRNA. However, they synergized with MKK6 in induction of IL-8 protein [13 ].

Collectively, these findings indicate that the p38 MAPK pathway contributes to cytokine/stress-induced IL-8 gene expression by stabilizing mRNAs through an MK2-dependent, ARE-targeted mechanism (Figs. 3 and 4 ).



View larger version (43K):
[in this window]
[in a new window]
  		Figure 3. Essential signal transduction steps in cytokine-mediated IL-8 gene regulation. In unstimulated cells, the NRF prevents IL-8 transcription [45]. IL-1 or TNF-{alpha} binding to the cell surface results in formation of multimeric receptor complexes that recruit the adaptor proteins TRAF6 or TRAF2, respectively [32, 100, 101]. TRAF oligomerization triggers activation of MAPKKK, such as TAK1, NIK, or MEKK1 by unknown mechanisms [32, 100, 101]. TAK1 or MEKK1 activates the MKK7-JNK and the IKK-ß/-{gamma} pathways [13, 43, 45, 73, 74]. The direct targets of JNK as well as the proteins binding to the AP-1 site have not been identified, whereas IKK phosphorylates I{kappa}B, allowing release of NF-{kappa}B [70]. The p65 subunit of NF-{kappa}B translocates to the nucleus and binds to the NF-{kappa}B site of the IL-8 promoter [62, 45]. There, it interacts with constitutively bound NRF and AP-1 transcription factors [13, 45]. Post-translational modifications, such as phosphorylation of the transactivation domains of AP-1 [69] and NF-{kappa}B [59 ], coactivator (CBP/p300) recruitment [64], and histone phosphorylation or acetylation [61, 64, 95], result in chromatin remodeling and strong IL-8 transcription. The cis-elements for AP-1, NF-{kappa}B, or NRF cannot be altered without decreasing JNK or NF-{kappa}B-mediated IL-8 trancription [13, 45], favoring a model where all the proteins involved in transcription interact to form a multiprotein complex. This enhanceosome-like structure favors maximal contact with the RNA polymerase II holoenzyme, which itself becomes phosphorylated [84]. The newly synthesized transcript is then rapidly stabilized by the p38 MAPK pathway, which targets ARE in the IL-8 mRNA through an unknown mechanism that may involve proteins binding to the ARE [e.g., AU-binding factor 1 (AUF1) or embryonic lethal abnormal vision-like RNA-binding protein HuR] [31]. Essential steps in signal transmission and gene expression are shaded in gray. eIF, eukaryotic initiation factor; P, phosphorylation; PABP, polyA-binding protein.


arrow
REGULATION OF IL-8 EXPRESSION BY THE ERK PATHWAY
 
Although, as reported so far, the role of the NF-{kappa}B, JNK, and p38 pathways in IL-8 gene regulation has been analyzed in detail, information about the role of other signaling molecules (MKK1) is very limited (see Table 1 ). Based on use of the MEK1 inhibitors PD9805 and U0126, there is some evidence that the ERK pathway contributes to IL-8 expression (Table 1) . We found that EGF, a physiological activator of ERK, weakly induces IL-8 in a JNK- and NF-{kappa}B-independent manner [13 ]. Furthermore, expression of a constitutively active mutant of MEK1 causes some IL-8 transcription but fails to induce significant IL-8 protein (M. Kracht and E. Hoffmann, unpublished observations). These data suggest that the ERK pathway on its own is not a very potent inducer of IL-8 but has the potential to contribute to IL-8 induction stimulated by NF-{kappa}B and other pathways.


arrow
COORDINATED ACTIVATION OF THE NF-{kappa}B, JNK, AND P38 MAPK PATHWAYS BY MAPKK KINASES (MAPKKK) STRONGLY INDUCES IL-8
 
The data discussed so far support a model where significant IL-8 expression requires activation of NF-{kappa}B and at least one or two MAPK pathways. This raises the question of how cytokine receptors coordinate this activation.

MAPKKK comprise a remarkably large group of distinct enzymes, namely Raf-1, A-Raf, B-Raf, Mos, NIK, MEKK1–4, MLK2, MLK3, DLK/MUK, ASK1, Tpl-2/Cot, and transforming growth factor-ß-activated protein kinase 1 (TAK1). Although structurally quite different, MAPKKK phosphorylate and activate MAPKK and thereby activate MAPK. The JNK and p38 MAPK signaling pathways can be activated by ectopically expressed MEKK1–4, MLK2, MLK3, DLK/MUK, ASK1, Tpl-2/Cot, and TAK1, albeit to varying degrees [102 ].

IKK are activated by phosphorylation of serine 176 and 180 in the T-loop of the kinase domain [103 ]. This motif resembles the regulatory sequence in MAPKK, which is phosphorylated by MAPKKK. In agreement with that observation, an increasing number of MAPKKK have been shown recently to phosphorylate IKK and activate NF-{kappa}B. Of those, MEKK1, 2, and 3, Tpl-2/Cot, and TAK1 also activate JNK and p38 MAPK, and NIK is the only NF-{kappa}B-specific MAPKKK [13 , 31 , 43 , 45 , 100 101 102 , 104 ]. Thus, apparently some MAPKKK, like cellular stress or the proinflammatory cytokines IL-1 or TNF, can trigger two or three stress-kinase pathways simultaneously. However, knowledge is still limited as to which of the many MAPKKK link these pathways to the receptors for physiological inducers of IL-8, such as IL-1 or TNF [104 ].

It is interesting that the MAPKKK, MEKK1, and TAK1, which can activate NF-{kappa}B, JNK, and p38 MAPK, very potently induce IL-8 formation [13 , 43 , 45 ]. Furthermore, both kinases are activated by oligomerized adaptor proteins, TNF-receptor-associated factors (TRAF)-2 or -6, respectively. TRAFs link the IL-1 or TNF receptors to cytosolic signaling pathways by, so far, poorly characterized mechanisms [32 , 100 ].

Evidence for a central role of the TAK1 protein kinase in IL-8 expression was found recently. Expression of a kinase-inactive mutant of TAK1 largely blocked IL-1- or TNF-induced transcription and mRNA stabilization (ref. [43 ], and M. Kracht and J. Enninga, unpublished observations).

Activation of TAK1 is crucially dependent on interaction with the adaptor protein TAB1 [100 ]. A truncated version of TAB1, lacking the TAK1-binding domain, or a TAK1-derived peptide containing a TAK1-autoinhibitory domain was also efficient in inhibition. TAB1-activated TAK1 induced IL-8 transcription, mRNA stabilization, and protein formation [43 ]. These data establish the TAK1-TAB1 complex as an intracellular effector that controls the main steps of IL-8 gene expression. Additional experiments showed that downstream of TAK1, signaling diverges to regulate distinct steps in IL-8 expression. TAB1-TAK1-induced transcription was blocked by a kinase-inactive mutant of JNK2, whereas a kinase-inactive mutant of p38 MAPK had no effect. Conversely, TAB1-TAK1-induced mRNA stabilization was blocked by a kinase-inactive mutant of p38 MAPK but not by a kinase-inactive mutant of JNK2. Thus, downstream of active TAK1, NF-{kappa}B and JNK2 as well as p38 MAPK are targeted to distinct gene-regulatory functions by, so far, unknown mechanisms [43 ].

These results provide evidence that maximal IL-8 gene expression requires the coordinate action of at least three different signal transduction pathways that cooperate to induce mRNA synthesis and suppress mRNA degradation. Importantly, this three-pathway model of IL-8 induction is operative in response to a physiological stimulus IL-1, and the MAPKKK TAK1 plays a central and nonredundant role in coupling the IL-1 receptor to transcriptional and RNA-targeted mechanisms mediated by the three pathways [13 , 31 , 43 , 45 ].


arrow
CONCLUSIONS
 
From these data, a model for signal-dependent IL-8 gene regulation can be derived. IL-8 production is actively kept low in the absence of external stimulation (Fig. 2) . During stimulation, conserved signaling pathways activate IL-8 expression at the transcriptional and post-transcriptional levels (Figs. 3 and 4) . Maximal IL-8 amounts can only be generated if the gene promoter is derepressed, NF-{kappa}B and JNK pathways are activated to induce transcription, and the resulting mRNA is rapidly stabilized by the p38 MAPK pathway (Figs. 3 and 4) . In that way, cells are able to rapidly increase and at the same time, to fine-tune the amount of IL-8 secreted and thereby control the extent of leukocytes attracted to sites of tissue injury. The components of the involved pathways are not only ubiquitously expressed but are also activated by numerous stimuli, a fact that explains why so many cells are capable to react with a uniform, biological response, i.e., IL-8 secretion to external challenge. It is also important to note that the type of signal-dependent gene expression described here is not restricted to IL-8 but may also be relevant for many other proteins, e.g., IL-6 expressed during an inflammatory response. Therefore, therapeutic targeting of the production of IL-8 (and of other inflammatory proteins) may most effectively be achieved by inhibiting key intracellular signaling molecules.

Received March 25, 2002; accepted April 23, 2002.


arrow
REFERENCES
 
    1
  1. Zlotnik, A., Yoshie, O. (2000) Immunity 12,121-127[Medline]
    2. 2
  2. Baggiolini, M., Clark-Lewis, I. (1992) FEBS Lett. 307,97-101[Medline]
    3. 3
  3. Kasahara, T., Mukaida, N., Yamashita, K., Yagisawa, H., Akahoshi, T., Matsushima, K. (1991) Immunology 74,60-67[Medline]
    4. 4
  4. Brasier, A. R., Jamaluddin, M., Casola, A., Duan, W., Shen, Q., Garofalo, R. P. (1998) J. Biol. Chem. 273,3551-3561[Abstract/Free Full Text]
    5. 5
  5. Aihara, M., Tsuchimoto, D., Takizawa, H., Azuma, A., Wakebe, H., Ohmoto, Y., Imagawa, K., Kikuchi, M., Mukaida, N., Matsushima, K. (1997) Inf. Immun. 65,3218-3224[Abstract]
    6. 6
  6. Hobbie, S., Chen, L. M., Davis, R. J., Gala, J. E. (1997) J. Immunol. 159,5550-5559[Abstract]
    7. 7
  7. Mastronarde, J. G., Monick, M. M., Mukaida, N., Matsushima, K., Hunninghake, G. W. (1998) J. Infect. Dis. 177,1275-1281[Medline]
    8. 8
  8. Murayama, T., Ohara, Y., Obuchi, M., Khabar, K. S. A., Higashi, H., Mukaida, N., Matsushima, K. (1997) J. Virol. 71,5692-5695[Abstract]
    9. 9
  9. DeForge, L. E., Preston, A. M., Takeuchi, E., Kenney, J., Boxer, L. A., Remick, D. G. (1993) J. Biol. Chem. 268,25568-25576[Abstract/Free Full Text]
    10. 10
  10. Lee, L-F., Haskill, S. J., Mukaida, N., Matsushima, K., Ting, J. P-Y. (1997) Mol. Cell. Biol. 17,5097-5105[Abstract]
    11. 11
  11. Shapiro, L., Dinarello, C. A. (1995) Proc. Natl. Acad. Sci. USA 92,12230-12234[Abstract/Free Full Text]
    12. 12
  12. Sonoda, Y., Kasahara, T., Yamaguchi, Y., Kuno, K., Matsushima, K., Mukaida, N. (1997) J. Biol. Chem. 272,15366-15372[Abstract/Free Full Text]
    13. 13
  13. Holtmann, H., Winzen, R., Holland, P., Eickemeier, S., Hoffmann, E., Wallach, D., Malinin, N. L., Cooper, J. A., Resch, K., Kracht, M. (1999) Mol. Cell. Biol. 19,6742-6753[Abstract/Free Full Text]
    14. 14
  14. Alcorn, M. J., Booth, J. L., Coggeshall, K. M., Metcalf, J. P. (2001) J. Virol. 75,6450-6459[Abstract/Free Full Text]
    15. 15
  15. Liu, R., O’Connell, M., Johnson, K., Pritzker, K., Mackman, N., Terkeltaub, R. (2000) Arthritis Rheum. 43,1145-1155[Medline]
    16. 16
  16. Scherle, P. A., Jones, E. A., Favata, M. F., Daulerio, A. J., Covington, M. B., Nurnberg, S. A., Magolda, R. L., Trzaskos, J. M. (1998) J. Immunol. 161,5681-5686[Abstract/Free Full Text]
    17. 17
  17. Chen, W., Monick, M. M., Carter, A. B., Hunninghake, G. W. (2000) Exp. Lung Res. 26,13-26[Medline]
    18. 18
  18. Warny, M., Keates, A. C., Keates, S., Castagliuolo, I., Zacks, J. K., Aboudola, S., Qamar, A., Pothoulakis, C., LaMont, J. T., Kelly, C. P. (2000) J. Clin. Investig. 105,1147-1156[Medline]
    19. 19
  19. Manthey, C. L., Wang, S. W., Kinney, S. D., Yao, Z. (1998) J. Leukoc. Biol. 64,409-417[Abstract]
    20. 20
  20. Griego, S. D., Weston, C. B., Adams, J. L., Tal-Singer, R., Dillon, S. B. (2000) J. Immunol. 165,5211-5220[Abstract/Free Full Text]
    21. 21
  21. Arbabi, S., Garcia, I., Bauer, G. J., Maier, R. V. (1999) J. Immunol. 162,7441-7445[Abstract/Free Full Text]
    22. 22
  22. Albanyan, E. A., Vallejo, J. G., Smith, C. W., Edwards, M. S. (2000) Infect. Immun. 68,2053-2060[Abstract/Free Full Text]
    23. 23
  23. Gon, Y., Hashimoto, S., Matsumoto, K., Nakayama, T., Takeshita, I., Horie, T. (1998) Biochem. Biophys. Res. Commun. 249,156-160[Medline]
    24. 24
  24. Marie, C., Roman-Roman, S., Rawadi, G. (1999) Infect. Immun. 67,688-693[Abstract/Free Full Text]
    25. 25
  25. Eliopoulos, A. G., Gallagher, N. J., Blake, S. M., Dawson, C. W., Young, L. S. (1999) J. Biol. Chem. 274,16085-16096[Abstract/Free Full Text]
    26. 26
  26. Marin, V., Farnarier, C., Gres, S., Kaplanski, S., Su, M. S., Dinarello, C. A., Kaplanski, G. (2001) Blood 98,667-673[Abstract/Free Full Text]
    27. 27
  27. Suzuki, M., Tetsuka, T., Yoshida, S., Watanabe, N., Kobayashi, M., Matsui, N., Okamoto, T. (2000) FEBS Lett. 465,23-27[Medline]
    28. 28
  28. Mainiero, F., Soriani, A., Strippoli, R., Jacobelli, J., Gismondi, A., Piccoli, M., Frati, L., Santoni, A. (2000) Immunity 12,7-16[Medline]
    29. 29
  29. Feoktistov, I., Goldstein, A. E., Biaggioni, I. (1999) Mol. Pharmacol. 55,726-734[Abstract/Free Full Text]
    30. 30
  30. Friedland, J. S., Constantin, D., Shaw, T. C., Stylianou, E. (2001) J. Leukoc. Biol. 70,447-454[Abstract/Free Full Text]
    31. 31
  31. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Muller, M., Gaestel, M., Resch, K., Holtmann, H. (1999) EMBO J. 18,4969-4980[Medline]
    32. 32
  32. Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y., Karin, M. (1999) Genes Dev. 13,1297-1308[Abstract/Free Full Text]
    33. 33
  33. Vig, E., Green, M., Liu, Y., Donner, D. B., Mukaida, N., Goebl, M. G., Harrington, M. A. (1999) J. Biol. Chem. 274,13077-13084[Abstract/Free Full Text]
    34. 34
  34. Jobin, C., Holt, L., Bradham, C. A., Streetz, K., Brenner, D. A., Sartor, R. B. (1999) J. Immunol. 162,4447-4454[Abstract/Free Full Text]
    35. 35
  35. Lee, L. F., Li, G., Templeton, D. J., Ting, J. P. (1998) J. Biol. Chem. 273,28253-28260[Abstract/Free Full Text]
    36. 36
  36. Hippenstiel, S., Soeth, S., Kellas, B., Fuhrmann, O., Seybold, J., Krull, M., Eichel-Streiber, C., Goebeler, M., Ludwig, S., Suttorp, N. (2000) Blood 95,3044-3051[Abstract/Free Full Text]
    37. 37
  37. Shono, T., Ono, M., Izumi, H., Jimi, S. I., Matsushima, K., Okamoto, T., Kohno, K., Kuwano, M. (1996) Mol. Cell. Biol. 16,4231-4239[Abstract]
    38. 38
  38. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., Kuwano, M. (1997) Mol. Cell. Biol. 17,4015-4023[Abstract]
    39. 39
  39. Kunsch, C., Rosen, C. A. (1993) Mol. Cell. Biol. 13,6137-6146[Abstract/Free Full Text]
    40. 40
  40. Georganas, C., Liu, H., Perlman, H., Hoffmann, A., Thimmapaya, B., Pope, R. M. (2000) J. Immunol. 165,7199-7206[Abstract/Free Full Text]
    41. 41
  41. Huang, S., DeGuzman, A., Bucana, C. D., Fidler, I. J. (2000) Cytokines Cell. Mol. Ther. 6,9-17[Medline]
    42. 42
  42. Aupperle, K., Bennett, B., Han, Z., Boyle, D., Manning, A., Firestein, G. (2001) J. Immunol. 166,2705-2711[Abstract/Free Full Text]
    43. 43
  43. Holtmann, H., Enninga, J., Kalble, S., Thiefes, A., Dorrie, A., Broemer, M., Winzen, R., Wilhelm, A., Ninomiya-Tsuji, J., Matsumoto, K., Resch, K., Kracht, M. (2001) J. Biol. Chem. 276,3508-3516[Abstract/Free Full Text]
    44. 44
  44. Krause, A., Holtmann, H., Eickemeier, S., Winzen, R., Szamel, M., Resch, K., Saklatvala, J., Kracht, M. (1998) J. Biol. Chem. 273,23681-23689[Abstract/Free Full Text]
    45. 45
  45. Nourbakhsh, M., Kalble, S., Dorrie, A., Hauser, H., Resch, K., Kracht, M. (2001) J. Biol. Chem. 276,4501-4508[Abstract/Free Full Text]
    46. 46
  46. Natarajan, R., Gupta, S., Fisher, B. J., Ghosh, S., Fowler, A. A., III (2001) Exp. Cell Res. 266,203-212[Medline]
    47. 47
  47. Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., Sartor, R. B. (1999) J. Immunol. 163,3474-3483[Abstract/Free Full Text]
    48. 48
  48. Funakoshi, M., Sonoda, Y., Tago, K., Tominaga, S., Kasahara, T. (2001) Int. Immunopharmacol. 1,595-604[Medline]
    49. 49
  49. Yu, Y., Chadee, K. (1998) J. Immunol. 161,3746-3752[Abstract/Free Full Text]
    50. 50
  50. Yu, Y., De Waele, C., Chadee, K. (2001) Inflamm. Res. 50,220-226[Medline]
    51. 51
  51. Bocker, U., Schottelius, A., Watson, J. M., Holt, L., Licato, L. L., Brenner, D. A., Sartor, R. B., Jobin, C. (2000) J. Biol. Chem. 275,12207-12213[Abstract/Free Full Text]
    52. 52
  52. Zidovetzki, R., Chen, P., Chen, M., Hofman, F. M. (1999) Blood 94,1291-1299[Abstract/Free Full Text]
    53. 53
  53. Bruder, J. T., Kovesdi, I. (1997) J. Virol. 71,398-404[Abstract]
    54. 54
  54. Li, S. D., Kersulyte, D., Lindley, I. J., Neelam, B., Berg, D. E., Crabtree, J. E. (1999) Infect. Immun. 67,3893-3899[Abstract/Free Full Text]
    55. 55
  55. Harant, H., deMartin, R., Andrew, P. J., Foglar, E., Dittrich, C., Lindley, I. J. D. (1996) J. Biol. Chem. 271,26954-26961[Abstract/Free Full Text]
    56. 56
  56. Mukaida, N., Mahe, Y., Matsushima, K. (1990) J. Biol. Chem. 265,21128-21133[Abstract/Free Full Text]
    57. 57
  57. Mukaida, N., Okamoto, S., Ishikawa, Y., Matsushima, K. (1994) J. Leukoc. Biol. 56,554-558[Abstract]
    58. 58
  58. Baeuerle, P. A., Baltimore, D. (1996) Cell 87,13-20[Medline]
    59. 59
  59. Schmitz, M. L., Bacher, S., Kracht, M. (2001) Trends Biochem. Sci. 26,186-190[Medline]
    60. 60
  60. Matsukaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., Akira, S. (1993) Proc. Natl. Acad. Sci. USA 90,10193-10197[Abstract/Free Full Text]
    61. 61
  61. Ashburner, B. P., Westerheide, S. D., Baldwin, A. S., Jr (2001) Mol. Cell. Biol. 21,7065-7077[Abstract/Free Full Text]
    62. 62
  62. Chen, Y. Q., Ghosh, S., Ghosh, G. (1998) Nat. Struct. Biol. 5,67-73[Medline]
    63. 63
  63. Stein, B., Baldwin, A. S., Jr (1993) Mol. Cell. Biol. 13,7191-7198[Abstract/Free Full Text]
    64. 64
  64. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S., Haegeman, G. (1999) J. Biol. Chem. 274,32091-32098[Abstract/Free Full Text]
    65. 65
  65. Kunsch, C., Lang, R. K., Rosen, C. A., Shannon, M. F. (1994) J. Immunol. 153,153-163[Abstract]
    66. 66
  66. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., Matsushima, K. (1994) J. Biol. Chem. 269,13289-13295[Abstract/Free Full Text]
    67. 67
  67. Wu, G. D., Lai, E. J., Huang, N., Wen, X. (1997) J. Biol. Chem. 272,2396-2403[Abstract/Free Full Text]
    68. 68
  68. Karin, M., Liu, Z., Zandi, E. (1997) Curr. Opin. Cell Biol. 9,240-246[Medline]
    69. 69
  69. Whitmarsh, A. J., Davis, R. J. (1996) J. Mol. Med. 74,589-607[Medline]
    70. 70
  70. Zandi, E., Karin, M. (1999) Mol. Cell. Biol. 19,4547-4551[Free Full Text]
    71. 71
  71. Davis, R. J. (2000) Cell 103,239-252[Medline]
    72. 72
  72. Nebreda, A. R., Porras, A. (2000) Trends Biochem. Sci. 25,257-260[Medline]
    73. 73
  73. Chu, W. M., Ostertag, D., Li, Z. W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., Karin, M. (1999) Immunity 11,721-731[Medline]
    74. 74
  74. Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israel, A., Rajewsky, K., Pasparakis, M. (2000) Mol. Cell 5,981-992[Medline]
    75. 75
  75. Bennett, B. L., Sasaki, D. T., Murray, B. W., O’Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., Anderson, D. W. (2001) Proc. Natl. Acad. Sci. USA 98,13681-13686[Abstract/Free Full Text]
    76. 76
  76. Ip, Y. T., Davis, R. J. (1998) Curr. Opin. Cell Biol. 10,205-219[Medline]
    77. 77
  77. Kracht, M. (2000) Eur. Cytokine Netw. 11,497-499[Medline]
    78. 78
  78. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., Maniatis, T. (1998) Mol. Cell 1,507-518[Medline]
    79. 79
  79. Falvo, J. V., Parekh, B. S., Lin, C. H., Fraenkel, E., Maniatis, T. (2000) Mol. Cell. Biol. 20,4814-4825[Abstract/Free Full Text]
    80. 80
  80. Carey, M. (1998) Cell 92,5-8[Medline]
    81. 81
  81. Cheung, P., Allis, C. D., Sassone-Corsi, P. (2000) Cell 103,263-271[Medline]
    82. 82
  82. Janknecht, R., Hunter, T. (1996) Nature 383,22-23[Medline]
    83. 83
  83. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., Nakatani, Y. (1996) Cell 87,953-959[Medline]
    84. 84
  84. Nissen, R. M., Yamamoto, K. R. (2000) Genes Dev. 14,2314-2329[Abstract/Free Full Text]
    85. 85
  85. Nourbakhsh, M., Hoffmann, K., Hauser, H. (1993) EMBO J. 12,451-459[Medline]
    86. 86
  86. Nourbakhsh, M., Hauser, H. (1999) EMBO J. 18,6415-6425[Medline]
    87. 87
  87. Bird, T. A., Schooley, K., Dower, S. K., Hagen, H., Virca, G. D. (1997) J. Biol. Chem. 272,32606-32612[Abstract/Free Full Text]
    88. 88
  88. Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., Ghosh, S. (1997) Cell 89,413-424[Medline]
    89. 89
  89. Zhong, H., Voll, R. E., Ghosh, S. (1998) Mol. Cell 1,661-671[Medline]
    90. 90
  90. Stein, B., Baldwin, A. S., Jr, Ballard, D. W., Greene, W. C., Angel, P., Herrlich, P. (1993) EMBO J. 12,3879-3891[Medline]
    91. 91
  91. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., Collins, T. (1997) Proc. Natl. Acad. Sci. USA 94,2927-2932[Abstract/Free Full Text]
    92. 92
  92. Merika, M., Williams, A. J., Chen, G., Collins, T., Thanos, D. (1998) Mol. Cell 1,277-287[Medline]
    93. 93
  93. Schmitz, M. L., Stelzer, G., Altmann, H., Meisterernst, M., Baeuerle, P. A. (1995) J. Biol. Chem. 270,7219-7226[Abstract/Free Full Text]
    94. 94
  94. Nourbakhsh, M., Hauser, H. (1997) Immunobiology 198,65-72[Medline]
    95. 95
  95. Wen, X., Wu, G. D. (2001) J. Immunol. 166,7290-7299[Abstract/Free Full Text]
    96. 96
  96. Ridley, S. H., Sarsfield, S. J., Lee, J. C., Bigg, H. F., Cawston, T. E., Taylor, D. J., DeWitt, D. L., Saklatvala, J. (1997) J. Immunol. 158,3165-3173[Abstract]
    97. 97
  97. Davies, S. P., Reddy, H., Caivano, M., Cohen, P. (2000) Biochem. J. 351,95-105[Medline]
    98. 98
  98. Wysk, M., Yang, D. D., Lu, H. T., Flavell, R. A., Davis, R. J. (1999) Proc. Natl. Acad. Sci. USA 96,3763-3768[Abstract/Free Full Text]
    99. 99
  99. Allen, M., Svensson, L., Roach, M., Hambor, J., McNeish, J., Gabel, C. A. (2000) J. Exp. Med. 191,859-870[Abstract/Free Full Text]
    100. 100
  100. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., Matsumoto, K. (1999) Nature 398,252-256[Medline]
    101. 101
  101. Malinin, N. L., Boldin, M. P., Kovalenko, A. V., Wallach, D. (1997) Nature 385,540-544[Medline]
    102. 102
  102. Widmann, C., Gibson, S., Jarpe, M. B., Johnson, G. L. (1999) Physiol. Rev. 79,143-180[Abstract/Free Full Text]
    103. 103
  103. Delhase, M., Hayakawa, M., Chen, Y., Karin, M. (1999) Science 284,309-313[Abstract/Free Full Text]
    104. 104
  104. Karin, M., Delhase, M. (1998) Proc. Natl. Acad. Sci. USA 95,9067-9069[Free Full Text]

Related Articles

The 2006 Dolph Adams Award and the State of the Journal of Leukocyte Biology
Helene Rosenberg and Joost Oppenheim
J. Leukoc. Biol. 2007 81: 369-371. [Full Text] [PDF]

The 2005 Dolph Adams awards and the state of the Journal of Leukocyte Biology
Joost J. Oppenheim
J. Leukoc. Biol. 2006 79: 1-3. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
T. Arase, H. Uchida, T. Kajitani, M. Ono, K. Tamaki, H. Oda, S. Nishikawa, M. Kagami, T. Nagashima, H. Masuda, et al.
The UDP-Glucose Receptor P2RY14 Triggers Innate Mucosal Immunity in the Female Reproductive Tract by Inducing IL-8
J. Immunol., June 1, 2009; 182(11): 7074 - 7084.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. S. Balakathiresan, S. Bhattacharyya, U. Gutti, R. P. Long, C. Jozwik, W. Huang, M. Srivastava, H. B. Pollard, and R. Biswas
Tristetraprolin regulates IL-8 mRNA stability in cystic fibrosis lung epithelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1012 - L1018.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Moretto, F. Facchinetti, T. Southworth, M. Civelli, D. Singh, and R. Patacchini
{alpha},{beta}-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases
Am J Physiol Lung Cell Mol Physiol, May 1, 2009; 296(5): L839 - L848.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Ji, J. E. Shin, Y. S. Kim, J.-E. Oh, B.-M. Min, and Y. Choi
Toll-Like Receptor 2 and NALP2 Mediate Induction of Human Beta-Defensins by Fusobacterium nucleatum in Gingival Epithelial Cells
Infect. Immun., March 1, 2009; 77(3): 1044 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. D. N'Guessan, F. Riediger, K. Vardarova, S. Scharf, J. Eitel, B. Opitz, H. Slevogt, W. Weichert, A. C. Hocke, B. Schmeck, et al.
Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 380 - 386.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Tajima, T. Iwase, H. Shinji, K. Seki, and Y. Mizunoe
Inhibition of Endothelial Interleukin-8 Production and Neutrophil Transmigration by Staphylococcus aureus Beta-Hemolysin
Infect. Immun., January 1, 2009; 77(1): 327 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Magklara and C. L. Smith
A Composite Intronic Element Directs Dynamic Binding of the Progesterone Receptor and GATA-2
Mol. Endocrinol., January 1, 2009; 23(1): 61 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. M. Harrison, P. Rallabhandi, J. Michalski, X. Zhou, S. R. Steyert, S. N. Vogel, and J. B. Kaper
Vibrio cholerae Flagellins Induce Toll-Like Receptor 5-Mediated Interleukin-8 Production through Mitogen-Activated Protein Kinase and NF-{kappa}B Activation
Infect. Immun., December 1, 2008; 76(12): 5524 - 5534.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Eder, H. Guan, H. Y. Sung, J. Ward, A. Angyal, M. Janas, G. Sarmay, E. Duda, M. Turner, S. K. Dower, et al.
Tribbles-2 is a novel regulator of inflammatory activation of monocytes
Int. Immunol., December 1, 2008; 20(12): 1543 - 1550.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. N. Baranova, R. Kurlander, A. V. Bocharov, T. G. Vishnyakova, Z. Chen, A. T. Remaley, G. Csako, A. P. Patterson, and T. L. Eggerman
Role of Human CD36 in Bacterial Recognition, Phagocytosis, and Pathogen-Induced JNK-Mediated Signaling
J. Immunol., November 15, 2008; 181(10): 7147 - 7156.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Balloy, J.-M. Sallenave, Y. Wu, L. Touqui, J.-P. Latge, M. Si-Tahar, and M. Chignard
Aspergillus fumigatus-induced Interleukin-8 Synthesis by Respiratory Epithelial Cells Is Controlled by the Phosphatidylinositol 3-Kinase, p38 MAPK, and ERK1/2 Pathways and Not by the Toll-like Receptor-MyD88 Pathway
J. Biol. Chem., November 7, 2008; 283(45): 30513 - 30521.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
Y.-T. Siu, Y.-P. Ching, and D.-Y. Jin
Activation of TORC1 Transcriptional Coactivator through MEKK1-induced Phosphorylation
Mol. Biol. Cell, November 1, 2008; 19(11): 4750 - 4761.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Fischer, C. Suire, and H. Hale-Donze
Toll-Like Receptor 2 Recognition of the Microsporidia Encephalitozoon spp. Induces Nuclear Translocation of NF-{kappa}B and Subsequent Inflammatory Responses
Infect. Immun., October 1, 2008; 76(10): 4737 - 4744.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Liu, K. Kimura, R. Yanai, T.-i. Chikama, and T. Nishida
Cytokine, Chemokine, and Adhesion Molecule Expression Mediated by MAPKs in Human Corneal Fibroblasts Exposed to Poly(I:C)
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3336 - 3344.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Movahedi, C. Gysemans, D. Jacobs-Tulleneers-Thevissen, C. Mathieu, and D. Pipeleers
Pancreatic Duct Cells in Human Islet Cell Preparations Are a Source of Angiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor
Diabetes, August 1, 2008; 57(8): 2128 - 2136.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. F. Fernandes, J. Zhou, X. Zhang, Q. Bian, J. Sparrow, A. Taylor, P. Pereira, and F. Shang
Oxidative Inactivation of the Proteasome in Retinal Pigment Epithelial Cells: A POTENTIAL LINK BETWEEN OXIDATIVE STRESS AND UP-REGULATION OF INTERLEUKIN-8
J. Biol. Chem., July 25, 2008; 283(30): 20745 - 20753.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Schmeck, J. Lorenz, P. D. N'Guessan, B. Opitz, V. van Laak, J. Zahlten, H. Slevogt, M. Witzenrath, A. Flieger, N. Suttorp, et al.
Histone Acetylation and Flagellin Are Essential for Legionella pneumophila-Induced Cytokine Expression
J. Immunol., July 15, 2008; 181(2): 940 - 947.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. R. Buchholz and R. S. Stephens
The Cytosolic Pattern Recognition Receptor NOD1 Induces Inflammatory Interleukin-8 during Chlamydia trachomatis Infection
Infect. Immun., July 1, 2008; 76(7): 3150 - 3155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
V. Bezzerri, M. Borgatti, E. Nicolis, I. Lampronti, M. C. Dechecchi, I. Mancini, P. Rizzotti, R. Gambari, and G. Cabrini
Transcription Factor Oligodeoxynucleotides to NF-{kappa}B Inhibit Transcription of IL-8 in Bronchial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 86 - 96.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Rolny, L. Capparuccia, A. Casazza, M. Mazzone, A. Vallario, A. Cignetti, E. Medico, P. Carmeliet, P. M. Comoglio, and L. Tamagnone
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
J. Exp. Med., May 12, 2008; 205(5): 1155 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Hoffmann, J. Ashouri, S. Wolter, A. Doerrie, O. Dittrich-Breiholz, H. Schneider, E. F. Wagner, J. Troppmair, N. Mackman, and M. Kracht
Transcriptional Regulation of EGR-1 by the Interleukin-1-JNK-MKK7-c-Jun Pathway
J. Biol. Chem., May 2, 2008; 283(18): 12120 - 12128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. S. Mullan, M. Riley, D. Clarke, A. Tatler, A. Sutcliffe, A. J. Knox, and L. Pang
{beta}-Tryptase Regulates IL-8 Expression in Airway Smooth Muscle Cells by a PAR-2-Independent Mechanism
Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 600 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
B. Schmeck, W. Beermann, P. D. N'Guessan, A. C. Hocke, B. Opitz, J. Eitel, Q. T. Dinh, M. Witzenrath, M. Krull, N. Suttorp, et al.
Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
Circ. Res., April 25, 2008; 102(8): 888 - 895.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. A. Abdel-Malak, C. B. Srikant, A. S. Kristof, S. A. Magder, J. A. Di Battista, and S. N. A. Hussain
Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8
Blood, April 15, 2008; 111(8): 4145 - 4154.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. A. Khan, S. Bouzari, C. Ma, C. M. Rosenberger, K. S. B. Bergstrom, D. L. Gibson, T. S. Steiner, and B. A. Vallance
Flagellin-Dependent and -Independent Inflammatory Responses following Infection by Enteropathogenic Escherichia coli and Citrobacter rodentium
Infect. Immun., April 1, 2008; 76(4): 1410 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
M. T. Scupoli, M. Donadelli, F. Cioffi, M. Rossi, O. Perbellini, G. Malpeli, S. Corbioli, F. Vinante, M. Krampera, M. Palmieri, et al.
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-{kappa}B and JNK/AP-1 pathways
Haematologica, April 1, 2008; 93(4): 524 - 532.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. Sillanpaa, P. Kaukinen, K. Melen, and I. Julkunen
Hepatitis C virus proteins interfere with the activation of chemokine gene promoters and downregulate chemokine gene expression
J. Gen. Virol., February 1, 2008; 89(2): 432 - 443.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Thompson, A. Cloutier, Y. Bosse, C. Poisson, P. Larivee, P. P. McDonald, J. Stankova, and M. Rola-Pleszczynski
Signaling by the Cysteinyl-Leukotriene Receptor 2: INVOLVEMENT IN CHEMOKINE GENE TRANSCRIPTION
J. Biol. Chem., January 25, 2008; 283(4): 1974 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Muller, D. Viemann, M. Schmidt, N. Endres, S. Ludwig, M. Leverkus, J. Roth, and M. Goebeler
Candida albicans Triggers Activation of Distinct Signaling Pathways to Establish a Proinflammatory Gene Expression Program in Primary Human Endothelial Cells
J. Immunol., December 15, 2007; 179(12): 8435 - 8445.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
E. N. Benveniste and H. Qin
Type I Interferons as Anti-Inflammatory Mediators
Sci. Signal., December 11, 2007; 2007(416): pe70 - pe70.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. R. Buchholz and R. S. Stephens
The Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Induces the Inflammatory Factor Interleukin-8 following Chlamydia trachomatis Infection
Infect. Immun., December 1, 2007; 75(12): 5924 - 5929.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. Winzen, B. K. Thakur, O. Dittrich-Breiholz, M. Shah, N. Redich, S. Dhamija, M. Kracht, and H. Holtmann
Functional Analysis of KSRP Interaction with the AU-Rich Element of Interleukin-8 and Identification of Inflammatory mRNA Targets
Mol. Cell. Biol., December 1, 2007; 27(23): 8388 - 8400.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. F. A. Vogel, E. Sciullo, W. Li, P. Wong, G. Lazennec, and F. Matsumura
RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription
Mol. Endocrinol., December 1, 2007; 21(12): 2941 - 2955.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
T. Minami, T. Kuroishi, A. Ozawa, H. Shimauchi, Y. Endo, and S. Sugawara
Histamine Amplifies Immune Response of Gingival Fibroblasts
Journal of Dental Research, November 1, 2007; 86(11): 1083 - 1088.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
N. Ade, D. Antonios, S. Kerdine-Romer, F. Boisleve, F. Rousset, and M. Pallardy
NF-{kappa}B Plays a Major Role in the Maturation of Human Dendritic Cells Induced by NiSO4 but not by DNCB
Toxicol. Sci., October 1, 2007; 99(2): 488 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Weigert, N. Tzieply, A. von Knethen, A. M. Johann, H. Schmidt, G. Geisslinger, and B. Brune
Tumor Cell Apoptosis Polarizes Macrophages Role of Sphingosine-1-Phosphate
Mol. Biol. Cell, October 1, 2007; 18(10): 3810 - 3819.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. A. Ehses, A. Perren, E. Eppler, P. Ribaux, J. A. Pospisilik, R. Maor-Cahn, X. Gueripel, H. Ellingsgaard, M. K.J. Schneider, G. Biollaz, et al.
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Diabetes, September 1, 2007; 56(9): 2356 - 2370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Wiehler and D. Proud
Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L505 - L515.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. Saadane, S. Masters, J. DiDonato, J. Li, and M. Berger
Parthenolide Inhibits I{kappa}B Kinase, NF-{kappa}B Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice
Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 728 - 736.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Lecine, S. Esmiol, J.-Y. Metais, C. Nicoletti, C. Nourry, C. McDonald, G. Nunez, J.-P. Hugot, J.-P. Borg, and V. Ollendorff
The NOD2-RICK Complex Signals from the Plasma Membrane
J. Biol. Chem., May 18, 2007; 282(20): 15197 - 15207.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. O'Kane, J. J. Boyle, D. E. Horncastle, P. T. Elkington, and J. S. Friedland
Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages
J. Immunol., March 15, 2007; 178(6): 3767 - 3776.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
S. M. Fennewald, E. P. Scott, L. Zhang, X. Yang, J. F. Aronson, D. G. Gorenstein, B. A. Luxon, R. E. Shope, D. W. C. Beasley, A. D. T. Barrett, et al.
Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections
J. Gen. Virol., March 1, 2007; 88(3): 981 - 990.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Bonnefont, L. Daulhac, M. Etienne, E. Chapuy, C. Mallet, L. Ouchchane, C. Deval, J.-P. Courade, M. Ferrara, A. Eschalier, et al.
Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic System
Mol. Pharmacol., February 1, 2007; 71(2): 407 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt
Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Wullaert, L. Verstrepen, S. Van Huffel, M. Adib-Conquy, S. Cornelis, M. Kreike, M. Haegman, K. El Bakkouri, M. Sanders, K. Verhelst, et al.
LIND/ABIN-3 Is a Novel Lipopolysaccharide-inducible Inhibitor of NF-{kappa}B Activation
J. Biol. Chem., January 5, 2007; 282(1): 81 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. M. Brinkmann, M. Pietrek, O. Dittrich-Breiholz, M. Kracht, and T. F. Schulz
Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., January 1, 2007; 81(1): 42 - 58.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Wagoner, M. Austin, J. Green, T. Imaizumi, A. Casola, A. Brasier, K. S. A. Khabar, T. Wakita, M. Gale Jr., and S. J. Polyak
Regulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus Infection
J. Virol., January 1, 2007; 81(1): 309 - 318.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. L. Kirkwood, F. Li, J. E. Rogers, J. Otremba, D. D. Coatney, J. M. Kreider, N. J. D'Silva, S. Chakravarty, S. Dugar, L. S. Higgins, et al.
A p38{alpha} Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 56 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Z. Fu, K. Bettega, S. Carroll, K. R. Buchholz, and T. E. Machen
Role of Ca2+ in responses of airway epithelia to Pseudomonas aeruginosa, flagellin, ATP, and thapsigargin
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L353 - L364.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Blau, K. Klein, I. Shalit, D. Halperin, and I. Fabian
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-{kappa}B activation in a cystic fibrosis epithelial cell line
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L343 - L352.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Thompson, A. Cloutier, Y. Bosse, M. Thivierge, C. L. Gouill, P. Larivee, P. P. McDonald, J. Stankova, and M. Rola-Pleszczynski
CysLT1 Receptor Engagement Induces Activator Protein-1- and NF-{kappa}B-Dependent IL-8 Expression
Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 697 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Davidson, A. J. Currie, D. M. E. Bowdish, K. L. Brown, C. M. Rosenberger, R. C. Ma, J. Bylund, P. A. Campsall, A. Puel, C. Picard, et al.
IRAK-4 Mutation (Q293X): Rapid Detection and Characterization of Defective Post-Transcriptional TLR/IL-1R Responses in Human Myeloid and Non-Myeloid Cells
J. Immunol., December 1, 2006; 177(11): 8202 - 8211.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Holloway and B. S. Coulson
Rotavirus Activates JNK and p38 Signaling Pathways in Intestinal Cells, Leading to AP-1-Driven Transcriptional Responses and Enhanced Virus Replication
J. Virol., November 1, 2006; 80(21): 10624 - 10633.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. K. Hakala, K. A. Lindstedt, P. T. Kovanen, and M. O. Pentikainen
Low-Density Lipoprotein Modified by Macrophage-Derived Lysosomal Hydrolases Induces Expression and Secretion of IL-8 Via p38 MAPK and NF-{kappa}B by Human Monocyte-Derived Macrophages
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2504 - 2509.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Nozell, T. Laver, K. Patel, and E. N. Benveniste
Mechanism of IFN-beta-Mediated Inhibition of IL-8 Gene Expression in Astroglioma Cells
J. Immunol., July 15, 2006; 177(2): 822 - 830.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. B. Patrone, S. E. Bish, and D. C. Stein
TNF-{alpha}-Independent IL-8 Expression: Alterations in Bacterial Challenge Dose Cause Differential Human Monocytic Cytokine Response
J. Immunol., July 15, 2006; 177(2): 1314 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Cuzick, F. R. Stirling, S. L. Lindsay, and T. J. Evans
The Type III Pseudomonal Exotoxin U Activates the c-Jun NH2-Terminal Kinase Pathway and Increases Human Epithelial Interleukin-8 Production
Infect. Immun., July 1, 2006; 74(7): 4104 - 4113.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Fernandez-Sesma, S. Marukian, B. J. Ebersole, D. Kaminski, M.-S. Park, T. Yuen, S. C. Sealfon, A. Garcia-Sastre, and T. M. Moran
Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein.
J. Virol., July 1, 2006; 80(13): 6295 - 6304.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
F. Delgado-Lopez and M. S. Horwitz
Adenovirus RID{alpha}{beta} Complex Inhibits Lipopolysaccharide Signaling without Altering TLR4 Cell Surface Expression.
J. Virol., July 1, 2006; 80(13): 6378 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
P. J. Lafontant, A. R. Burns, E. Donnachie, S. B. Haudek, C. W. Smith, and M. L. Entman
Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts
Am J Physiol Cell Physiol, July 1, 2006; 291(1): C18 - C26.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. A. Jarvis, J. A. Borton, A. M. Keech, J. Wong, W. J. Britt, B. E. Magun, and J. A. Nelson
Human Cytomegalovirus Attenuates Interleukin-1{beta} and Tumor Necrosis Factor Alpha Proinflammatory Signaling by Inhibition of NF-{kappa}B Activation.
J. Virol., June 1, 2006; 80(11): 5588 - 5598.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Henness, E. van Thoor, Q. Ge, C. L. Armour, J. M. Hughes, and A. J. Ammit
IL-17A acts via p38 MAPK to increase stability of TNF-{alpha}-induced IL-8 mRNA in human ASM
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1283 - L1290.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. A. Pioli, L. K. Weaver, T. M. Schaefer, J. A. Wright, C. R. Wira, and P. M. Guyre
Lipopolysaccharide-Induced IL-1beta Production by Human Uterine Macrophages Up-Regulates Uterine Epithelial Cell Expression of Human beta-Defensin 2.
J. Immunol., June 1, 2006; 176(11): 6647 - 6655.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. A. Delgado, J. F. Poschet, and V. Deretic
Nonclassical Pathway of Pseudomonas aeruginosa DNA-Induced Interleukin-8 Secretion in Cystic Fibrosis Airway Epithelial Cells.
Infect. Immun., May 1, 2006; 74(5): 2975 - 2984.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. B. Cowland, T. Muta, and N. Borregaard
IL-1beta-Specific Up-Regulation of Neutrophil Gelatinase-Associated Lipocalin Is Controlled by I{kappa}B-{zeta}
J. Immunol., May 1, 2006; 176(9): 5559 - 5566.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. Wang, H. Wang, J. Brown, T. Daikoku, W. Ning, Q. Shi, A. Richmond, R. Strieter, S. K. Dey, and R. N. DuBois
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
J. Exp. Med., April 17, 2006; 203(4): 941 - 951.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Adam, K. K. Hansen, O. F. Astudillo, L. Coulon, F. Bex, X. Duhant, E. Jaumotte, M. D. Hollenberg, and A. Jacquet
The House Dust Mite Allergen Der p 1, Unlike Der p 3, Stimulates the Expression of Interleukin-8 in Human Airway Epithelial Cells via a Proteinase-activated Receptor-2-independent Mechanism
J. Biol. Chem., March 17, 2006; 281(11): 6910 - 6923.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. G. Romero, G. R. Vergara, Z. Zhu, G. S. Covington, M. W. Plonczynski, L. L. Yanes, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez
Interleukin-8 Synthesis, Regulation, and Steroidogenic Role in H295R Human Adrenocortical Cells
Endocrinology, February 1, 2006; 147(2): 891 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Shinkai, G. H. Foster, and B. K. Rubin
Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L75 - L85.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. P. Carroll, C. M. Greene, C. C. Taggart, A. G. Bowie, S. J. O'Neill, and N. G. McElvaney
Viral Inhibition of IL-1- and Neutrophil Elastase-Induced Inflammatory Responses in Bronchial Epithelial Cells
J. Immunol., December 1, 2005; 175(11): 7594 - 7601.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Fan, N. M. Heller, M. Gorospe, U. Atasoy, and C. Stellato
The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy
Eur. Respir. J., November 1, 2005; 26(5): 933 - 947.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-W. Kim, M. Hayashi, J.-F. Lo, C. Fearns, R. Xiang, G. Lazennec, Y. Yang, and J.-D. Lee
Tid1 Negatively Regulates the Migratory Potential of Cancer Cells by Inhibiting the Production of Interleukin-8
Cancer Res., October 1, 2005; 65(19): 8784 - 8791.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. L. Medin, K. A. Fitzgerald, and A. L. Rothman
Dengue Virus Nonstructural Protein NS5 Induces Interleukin-8 Transcription and Secretion
J. Virol., September 1, 2005; 79(17): 11053 - 11061.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. G. Trevino, J. M. Summy, M. J. Gray, M. B. Nilsson, D. P. Lesslie, C. H. Baker, and G. E. Gallick
Expression and Activity of Src Regulate Interleukin-8 Expression in Pancreatic Adenocarcinoma Cells: Implications for Angiogenesis
Cancer Res., August 15, 2005; 65(16): 7214 - 7222.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Thiefes, S. Wolter, J. F. Mushinski, E. Hoffmann, O. Dittrich-Breiholz, N. Graue, A. Dorrie, H. Schneider, D. Wirth, B. Luckow, et al.
Simultaneous Blockade of NF{kappa}B, JNK, and p38 MAPK by a Kinase-inactive Mutant of the Protein Kinase TAK1 Sensitizes Cells to Apoptosis and Affects a Distinct Spectrum of Tumor Necrosis Target Genes
J. Biol. Chem., July 29, 2005; 280(30): 27728 - 27741.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Yang, W. Huang, C. Jozwik, Y. Lin, M. Glasman, H. Caohuy, M. Srivastava, D. Esposito, W. Gillette, J. Hartley, et al.
Cardiac glycosides inhibit TNF-{alpha}/NF-{kappa}B signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor
PNAS, July 5, 2005; 102(27): 9631 - 9636.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. Y. Fukuda, S. P. Lad, D. P. Mikolon, M. Iacobelli-Martinez, and E. Li
Activation of Lipid Metabolism Contributes to Interleukin-8 Production during Chlamydia trachomatis Infection of Cervical Epithelial Cells
Infect. Immun., July 1, 2005; 73(7): 4017 - 4024.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. H. Sohn, K. E. Lee, S. Y. Choi, B. C. Kwon, M. W. Chang, and K.-E. Kim
Effect of Mycoplasma pneumoniae Lysate on Interleukin-8 Gene Expression in Human Respiratory Epithelial Cells
Chest, July 1, 2005; 128(1): 322 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P.-L. Yao, Y.-C. Lin, C.-H. Wang, Y.-C. Huang, W.-Y. Liao, S.-S. Wang, J. J. W. Chen, and P.-C. Yang
Autocrine and Paracrine Regulation of Interleukin-8 Expression in Lung Cancer Cells
Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 540 - 547.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Kang, S. Cho, J. H. Chung, C. Hammerberg, G. J. Fisher, and J. J. Voorhees
Inflammation and Extracellular Matrix Degradation Mediated by Activated Transcription Factors Nuclear Factor-{kappa}B and Activator Protein-1 in Inflammatory Acne Lesions in Vivo
Am. J. Pathol., June 1, 2005; 166(6): 1691 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H.-O. Pae, G.-S. Oh, B.-M. Choi, Y.-M. Kim, and H.-T. Chung
A Molecular Cascade Showing Nitric Oxide-Heme Oxygenase-1-Vascular Endothelial Growth Factor-Interleukin-8 Sequence in Human Endothelial Cells
Endocrinology, May 1, 2005; 146(5): 2229 - 2238.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
T. Ishizu, M. Osoegawa, F.-J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, et al.
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Brain, May 1, 2005; 128(5): 988 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
D. J. Brat, A. C. Bellail, and E. G. Van Meir
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Neuro-oncol, April 1, 2005; 7(2): 122 - 133.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
E. Hoffmann, A. Thiefes, D. Buhrow, O. Dittrich-Breiholz, H. Schneider, K. Resch, and M. Kracht
MEK1-dependent Delayed Expression of Fos-related Antigen-1 Counteracts c-Fos and p65 NF-{kappa}B-mediated Interleukin-8 Transcription in Response to Cytokines or Growth Factors
J. Biol. Chem., March 11, 2005; 280(10): 9706 - 9718.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. J. Ratner, E. S. Lysenko, M. N. Paul, and J. N. Weiser
Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces
PNAS, March 1, 2005; 102(9): 3429 - 3434.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
T. Akerstrom, A. Steensberg, P. Keller, C. Keller, M. Penkowa, and B. K. Pedersen
Exercise induces interleukin-8 expression in human skeletal muscle
J. Physiol., March 1, 2005; 563(2): 507 - 516.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Guillot, R. Le Goffic, S. Bloch, N. Escriou, S. Akira, M. Chignard, and M. Si-Tahar
Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus
J. Biol. Chem., February 18, 2005; 280(7): 5571 - 5580.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Buss, A. Dorrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht
Constitutive and Interleukin-1-inducible Phosphorylation of p65 NF-{kappa}B at Serine 536 Is Mediated by Multiple Protein Kinases Including I{kappa}B Kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF Family Member-associated (TANK)-binding Kinase 1 (TBK1), and an Unknown Kinase and Couples p65 to TATA-binding Protein-associated Factor II31-mediated Interleukin-8 Transcription
J. Biol. Chem., December 31, 2004; 279(53): 55633 - 55643.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Schmeck, J. Zahlten, K. Moog, V. van Laak, S. Huber, A. C. Hocke, B. Opitz, E. Hoffmann, M. Kracht, J. Zerrahn, et al.
Streptococcus pneumoniae-induced p38 MAPK-dependent Phosphorylation of RelA at the Interleukin-8 Promotor
J. Biol. Chem., December 17, 2004; 279(51): 53241 - 53247.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y.-M. Wu, D. R. Robinson, and H.-J. Kung
Signal Pathways in Up-regulation of Chemokines by Tyrosine Kinase MER/NYK in Prostate Cancer Cells
Cancer Res., October 15, 2004; 64(20): 7311 - 7320.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Ovrevik, M. Lag, P. Schwarze, and M. Refsnes
p38 and Src-ERK1/2 Pathways Regulate Crystalline Silica-Induced Chemokine Release in Pulmonary Epithelial Cells
Toxicol. Sci., October 1, 2004; 81(2): 480 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. de Bruin, G. J. Peters, R. Oerlemans, Y. G. Assaraf, A. J. Masterson, A. D. Adema, B. A. C. Dijkmans, H. M. Pinedo, and G. Jansen
Sulfasalazine Down-Regulates the Expression of the Angiogenic Factors Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase and Interleukin-8 in Human Monocytic-Macrophage THP1 and U937 Cells
Mol. Pharmacol., October 1, 2004; 66(4): 1054 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. Sparkman and V. Boggaram
Nitric oxide increases IL-8 gene transcription and mRNA stability to enhance IL-8 gene expression in lung epithelial cells
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L764 - L773.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Si, M.-L. Zhao, A. C. A. Morgan, C. F. Brosnan, and S. C. Lee
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits IFN-Inducible Protein 10/CXC Chemokine Ligand 10 Expression in Human Microglia: Mechanisms and Implications
J. Immunol., September 1, 2004; 173(5): 3504 - 3513.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
S. Kreuz, D. Siegmund, J.-J. Rumpf, D. Samel, M. Leverkus, O. Janssen, G. Hacker, O. Dittrich-Breiholz, M. Kracht, P. Scheurich, et al.
NF{kappa}B activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP
J. Cell Biol., August 2, 2004; 166(3): 369 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. H. S. Chan, A. L. Carey, M. J. Watt, and M. A. Febbraio
Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R322 - R327.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Koch, M. Giembycz, R.G. Stirling, S. Lim, I. Adcock, K. Wassermann, E. Erdmann, and K.F. Chung
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages
Eur. Respir. J., June 1, 2004; 23(6): 805 - 812.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffmann, E.
Right arrow Articles by Kracht, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, E.
Right arrow Articles by Kracht, M.
Related Collections
Right arrowRelated Articles